Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Aytu BioScience stock | 1.02

Own Aytu BioScience stock in just a few minutes.

Posted

Fact checked

Aytu BioScience, Inc is a biotechnology business based in the US. Aytu BioScience shares (AYTU) are listed on the NASDAQ and all prices are listed in US Dollars. Aytu BioScience employs 75 staff and has a trailing 12-month revenue of around USD$27.6 million.

How to buy shares in Aytu BioScience

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Aytu BioScience. Find the stock by name or ticker symbol: AYTU. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aytu BioScience reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.02, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Aytu BioScience, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Aytu BioScience. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Aytu BioScience's share price?

Since the stock market crash in March caused by coronavirus, Aytu BioScience's share price has had significant positive movement.

Its last market close was USD$1.02, which is 26.18% up on its pre-crash value of USD$0.753 and 204.30% up on the lowest point reached during the March crash when the shares fell as low as USD$0.3352.

If you had bought USD$1,000 worth of Aytu BioScience shares at the start of February 2020, those shares would have been worth USD$2,630.10 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,434.60.

Aytu BioScience share price

Use our graph to track the performance of AYTU stocks over time.

Aytu BioScience shares at a glance

Information last updated 2020-10-20.
Latest market closeUSD$1.02
52-week rangeUSD$0.3352 - USD$2.99
50-day moving average USD$1.1623
200-day moving average USD$1.3723
Wall St. target priceUSD$2.63
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.481

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Tastyworks
$0
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aytu BioScience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aytu BioScience price performance over time

Historical closes compared with the close of $1.02 from 2020-10-19

1 week (2020-10-22) 0.99%
1 month (2020-09-29) -15.00%
3 months (2020-07-29) -25.55%
6 months (2020-04-29) -37.04%
1 year (2019-10-29) -4.67%
2 years (2018-10-29) -13.56%
3 years (2017-10-27) -72.43%
5 years (2015-10-29) -77.33%

Aytu BioScience financials

Revenue TTM USD$27.6 million
Gross profit TTM USD$20.1 million
Return on assets TTM -13.49%
Return on equity TTM -26.68%
Profit margin -49.29%
Book value $0.755
Market capitalisation USD$128.4 million

TTM: trailing 12 months

Shorting Aytu BioScience shares

There are currently 11.5 million Aytu BioScience shares held short by investors – that's known as Aytu BioScience's "short interest". This figure is 128.9% up from 5.0 million last month.

There are a few different ways that this level of interest in shorting Aytu BioScience shares can be evaluated.

Aytu BioScience's "short interest ratio" (SIR)

Aytu BioScience's "short interest ratio" (SIR) is the quantity of Aytu BioScience shares currently shorted divided by the average quantity of Aytu BioScience shares traded daily (recently around 3.4 million). Aytu BioScience's SIR currently stands at 3.33. In other words for every 100,000 Aytu BioScience shares traded daily on the market, roughly 3330 shares are currently held short.

However Aytu BioScience's short interest can also be evaluated against the total number of Aytu BioScience shares, or, against the total number of tradable Aytu BioScience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aytu BioScience's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Aytu BioScience shares in existence, roughly 90 shares are currently held short) or 0.0929% of the tradable shares (for every 100,000 tradable Aytu BioScience shares, roughly 93 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aytu BioScience.

Find out more about how you can short Aytu BioScience stock.

Aytu BioScience share dividends

We're not expecting Aytu BioScience to pay a dividend over the next 12 months.

Have Aytu BioScience's shares ever split?

Aytu BioScience's shares were split on a 1:20 basis on 13 August 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu BioScience shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Aytu BioScience shares which in turn could have impacted Aytu BioScience's share price.

Aytu BioScience share price volatility

Over the last 12 months, Aytu BioScience's shares have ranged in value from as little as $0.3352 up to $2.99. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu BioScience's is 0.1942. This would suggest that Aytu BioScience's shares are less volatile than average (for this exchange).

Aytu BioScience overview

Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site